Komabayashi Kenichi, Seto Junji, Tanaka Shizuka, Suzuki Yu, Ikeda Tatsuya, Onuki Noriko, Yamada Keiko, Ahiko Tadayuki, Ishikawa Hitoshi, Mizuta Katsumi
Department of Microbiology, Yamagata Prefectural Institute of Public Health.
Yamagata Prefecture Division of Health and Welfare Planning.
Jpn J Infect Dis. 2018 Nov 22;71(6):413-418. doi: 10.7883/yoken.JJID.2018.083. Epub 2018 Jun 29.
The incidence of modified measles (M-Me), characterized by milder symptoms than those of typical measles (T-Me), has been increasing in Japan. However, the outbreak dominated by M-Me cases has not been thoroughly investigated worldwide. The largest importation-related outbreak of measles with genotype D8 occurred in Yamagata Prefecture, Japan, from March to April 2017. This phenomenon was observed after Japan had achieved measles elimination in 2015. We confirmed 60 cases by detecting the genome of the measles virus (MeV). Among the cases, 38 were M-Me and 22 were T-Me. Thirty-nine (65.0%) patients were 20-39 years of age. Three out of 7 primary cases produced 50 transmissions, of which each patient caused 9-25 transmissions. These patients were 22-31 years old and were not vaccinated. Moreover, they developed T-Me and kept contact with the public during their symptomatic periods. Considering that M-Me is generally caused by vaccine failure, some individuals in Japan may have insufficient immunity for MeV. Accordingly, additional doses of measles vaccine may be necessary in preventing measles importation and endemicity among individuals aged 20-39 years. Furthermore, to accurately and promptly diagnose individuals with measles, particularly those who can be considered as primary cases, efforts must be exerted to detect all measles cases using epidemiological and genetic approaches in countries where measles elimination had been achieved.
在日本,以症状比典型麻疹(T-Me)更为轻微为特征的变异型麻疹(M-Me)发病率一直在上升。然而,全球范围内尚未对以M-Me病例为主的疫情进行全面调查。2017年3月至4月,日本山形县发生了最大规模的与输入相关的D8基因型麻疹疫情。这一现象是在日本于2015年实现麻疹消除之后观察到的。我们通过检测麻疹病毒(MeV)基因组确认了60例病例。其中,38例为M-Me,22例为T-Me。39名(65.0%)患者年龄在20至39岁之间。7例原发病例中有3例造成了50次传播,每名患者造成了9至25次传播。这些患者年龄在22至31岁之间,未接种疫苗。此外,他们患的是T-Me,在症状期与公众有接触。鉴于M-Me通常由疫苗失效引起,日本的一些人对MeV的免疫力可能不足。因此,可能有必要额外接种麻疹疫苗,以预防20至39岁人群中的麻疹输入和地方性流行。此外,为了准确、及时地诊断麻疹患者,特别是那些可被视为原发病例的患者,在已实现麻疹消除的国家,必须努力采用流行病学和基因方法检测所有麻疹病例。